The Omicron Variant Appears Less Likely to Cause Severe COVID-19 Illness Than Delta

Preliminary data suggest that people with the omicron variant of the coronavirus are between 50% and 70% less likely to need hospitalization than those with the delta strain, Britain’s public health agency said Thursday. The U.K. Health Security Agency findings add to emerging evidence that omicron produces milder illness than other variants—but also spreads faster … Read more

U.S. FDA Authorizes Merck’s COVID-19 Pill, Despite Experts Questioning Its Value

U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer. That pill is likely to become the first-choice treatment against the virus, thanks to … Read more

For Some, a Second Pandemic Winter Means Seasonal Affective Disorder Is Hitting Hard

Last winter, A.S.—a 26-year-old from Minnesota who asked to go by her initials to protect her privacy while job searching—was terrified of seasonal affective disorder (SAD). No stranger to seasonal depression during Minnesota’s cold, dark, snowy winters, A.S. worried that pandemic isolation would only make the problem worse. She planned a regimen of prescribed antidepressants, … Read more